Trust told to do harm reviews after patients drop off waiting list

Medway Clinical Commissioning Group asked Medway Foundation Trust to carry out harm reviews on patients who had waited more than 180 days to be found an appointment and find out why the number of patients affected by appointment slot issues at the trust was so high.

The trust said 42 reviews have been carried out so far with no evidence of harm uncovered.

Medway CCG, which is the trust’s main commissioner, had raised concerns in its latest governing body papers. It said that, although some ASI patients have been added to the normal patient administration system, “there is currently a lack of assurance that a sustainable process has been embedded to prevent a reoccurance”.

However, the CCG’s deputy managing director Stuart Jeffrey said this week: “A revised process is now in place to ensure future ASIs are managed in line with national guidance so we are confident the situation has been resolved.”

The trust said it had initiated “more robust” management and its ASI list was closely monitored to make sure patients did not “drop off”. There was a separate route in place for patients on the two-week referral pathway for suspected cancers.

The trust added: “When a patient is unable to book an appointment, due to there being no slots available, they are added to the ASI list. This list is accessible and managed by the operational teams at the trust which involves identifying, and in some instances, creating extra capacity. This can be a challenging situation and is dependent on other operational pressures as to how much extra capacity can be sourced.”